| Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant (NCT04239989) | M.D. Anderson Cancer Center | 2021-10-08 |
| TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients (NCT04098445) | Children's Hospital Medical Center, Cincinnati | 2021-09-08 |
| Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation (NCT04655508) | Assistance Publique - Hôpitaux de Paris | 2021-05-21 |
| Hp129 Xenon Imaging and BOS in Lung Transplantation (NCT03603899) | Children's Hospital Medical Center, Cincinnati | 2020-09-09 |
| Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome (NCT04604522) | M.D. Anderson Cancer Center | 2020-08-27 |
| Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) (NCT04039347) | Zambon SpA | 2020-03-12 |
| Study of Pulmonary MRI for the Diagnosis of Bronchiolitis Obliterans Syndrome After Allogeneic Stem Cell Transplantation (NCT04080232) | University Hospital, Bordeaux | 2020-02-06 |
| Hyperpolarized 129Xe MRI for the Assessment of BOS With Late Onset LONIPC (NCT04029636) | Hamilton Health Sciences Corporation | 2019-08-01 |
| INSPIRE Continuation Post-Approval Study (NCT03868904) | TransMedics | 2019-06-30 |
| Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2) (NCT03656926) | Zambon SpA | 2019-03-26 |
| Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) (NCT03657342) | Zambon SpA | 2019-03-26 |
| The Safety and Tolerability of Pirfenidone for BOS After HCT (NCT03315741) | Stanford University | 2018-03-01 |
| Measures of Respiratory Health (MRH) (NCT02657837) | The Hospital for Sick Children | 2016-01-01 |
| Lung Function, LCI, Bronchial Inflammation and Epigenetics of Patients With BO (NCT02627833) | Johann Wolfgang Goethe University Hospital | 2015-10-01 |
| Transplant Optimization Using Functional Imaging (TROFI) (NCT02441413) | FLUIDDA nv | 2015-09-01 |
| Prospective Study for Transplant Optimization Using Functional Imaging (TROFI) (NCT02488304) | FLUIDDA nv | 2015-07-01 |
| MSC for Treatment of Interstitial Lung Disease After Allo-HSCT (NCT02543073) | Nanfang Hospital, Southern Medical University | 2014-09-01 |
| Mesenchymal Stem Cell Therapy for Lung Rejection (NCT02181712) | Mayo Clinic | 2014-07-01 |
| Microparticles and Bronchiolitis Obliterans Syndrome (NCT02458274) | University Hospital, Strasbourg, France | 2014-07-01 |
| Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3 (NCT02109237) | The Prince Charles Hospital | 2014-05-01 |
| Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells. (NCT02032381) | Assistance Publique - Hôpitaux de Paris | 2014-01-01 |
| LCI and Bronchial Inflammation in Patients With BO (NCT02495597) | Johann Wolfgang Goethe University Hospital | 2013-04-01 |
| Bronchial Inflammation in Patients With Bronchiolithis Obliterans (NCT01633385) | Johann Wolfgang Goethe University Hospital | 2012-04-01 |
| Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) (NCT01439958) | Pari Pharma GmbH | 2012-02-01 |
| Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant (NCT01432080) | Maisonneuve-Rosemont Hospital | 2011-09-01 |
| Forced Oscillations for Diagnosis Help in Bronchiolitis Obliterans Syndrome in Post Bone Marrow Transplantation (NCT02902471) | Hopital Foch | 2011-06-01 |
| Targeted Therapy of Bronchiolitis Obliterans Syndrome (NCT01307462) | Stephanie Lee | 2011-06-01 |
| Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis Obliterans (NCT01327248) | Johann Wolfgang Goethe University Hospital | 2011-05-01 |
| Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans (NCT01327625) | Asan Medical Center | 2011-03-01 |
| Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (NCT01206309) | Fred Hutchinson Cancer Center | 2011-03-01 |
| Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome (NCT01287078) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-01-29 |
| A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD (NCT01163786) | Northwestern University | 2010-10-07 |
| Montelukast in Bronchiolitis Obliterans Syndrome (NCT01211509) | Universitaire Ziekenhuizen KU Leuven | 2010-10-01 |
| Vitamin D in Bronchiolitis Obliterans Syndrome (NCT01212406) | Universitaire Ziekenhuizen KU Leuven | 2010-10-01 |
| Efficacy and Safety of Azithromycin in Patients With Bronchiolitis Obliterans (NCT05299567) | Claudio Castanos | 2010-08-24 |
| A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation (NCT01175655) | The Prince Charles Hospital | 2010-02-01 |
| L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients (NCT01334892) | Pari Pharma GmbH | 2009-12-01 |
| Viral Triggers in Pediatric Lung Transplantation (NCT00891865) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-06-01 |
| Montelukast to Treat Bronchiolitis Obliterans (NCT00656058) | National Cancer Institute (NCI) | 2008-06-17 |
| Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation (NCT01560689) | Assistance Publique - Hôpitaux de Paris | 2008-06-01 |
| Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation (NCT00502554) | Hannover Medical School | 2007-08-01 |
| Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome (NCT00378677) | University Medical Center Groningen | 2007-02-01 |
| Prospective Evaluations of Infectious Complication in Lung Transplant Recipients (NCT00177918) | University of Pittsburgh | 2006-08-01 |
| Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease (NCT00163696) | Bayside Health | 2004-09-01 |
| Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant (NCT00141726) | University of Michigan Rogel Cancer Center | 2003-10-01 |
| Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation (NCT00029328) | FDA Office of Orphan Products Development | 2001-09-01 |
| Long-Term Study On Home Spirometry After Lung Transplantation (NCT00743171) | Hannover Medical School | 2000-01-01 |
| Popcorn Lung: the Discovery of a New Disease (NCT00027235) | National Center for Research Resources (NCRR) | |
| Use of Erythromycin in Mustard-Induced Bronchiolitis (NCT00367419) | Baqiyatallah Medical Sciences University | |
| Use of Clarithromycin in Mustard-Induced Bronchiolitis (NCT00381147) | Baqiyatallah Medical Sciences University | |